Abstract
Purpose: To investigate the angiogenic effect of the free acid of tafluprost (AFP-172) on human umbilical vascular endothelial cells (HUVECs). Methods: HUVECs cultured in the presence or absence of FP receptor antagonist (10 nM AL-8810) were exposed to escalating concentrations of 10-7, 10-6, 10-5, 10-4 and 10-3 M AFP-172 (the free acid of tafluprost). For cell proliferation assays, the numbers of cells were derived from a Cell-Titer96® Aqueous One Solution Cell Proliferation Assay (Promega) by Microplate reader (Bio-Rad, Benchmark). Endothelial cell migration was evaluated by a BD Biocoat™ Angiogenesis System using FluoroBlok™ 24-well inserts (BD Biosciences, Bedford, MA). BioTek FLx800 fluorescence plate reader was used for quantitative measurement of fluorescently-labeled invasive vascular endothelial cells. Endothelial capillary-like tube formation was evaluated by BD Biocoat Angiogenesis System using Matrigel Matrix 96-well plate. Real-time quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) was used to assess the gene expression of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2) and endothelial nitric oxide synthase (eNOS). COX-2 protein was detected by immunofluorescent staining and Western blot assay. Student's t-test was used for statistical analysis. Results: 10-4 M AFP-172 treated cells stimulated the proliferation, migration and tube formation of HUVECs as compared to 10-5, 10-6, 10-7 M AFP-172 treated cells and control (P<0.01). RT-PCR showed that incubation of HUVECs with 10 -4 M AFP-172 stimulated the expression of COX-2 mRNA (P<0.05). Western blot assay revealed that AFP-172 caused cells to increase in COX-2 protein at the concentrations of 10-4 M. Conclusions: >AFP-172 showed the angiogenic effects on HUVECs at the concentrations of 10-4 M by inducing COX-2 protein.
| Original language | English |
|---|---|
| Pages (from-to) | 1765-1775 |
| Number of pages | 11 |
| Journal | Graefe's Archive for Clinical and Experimental Ophthalmology |
| Volume | 250 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2012 |
Bibliographical note
Funding Information:Acknowledgments The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2010.
Keywords
- AFP-172
- Angiogenesis
- Human umbilical vein endothelial cell
- Tafluprost